1 | Ambrisentan (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 51 51, 84, 85, 86, 88, 210, 211 💬
|
2 | Ambrisentan - high dose (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
3 | Ambrisentan - low dose (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
4 | Ambrisentan 5 mg (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 88 88 💬
|
5 | Ambrisentan 5 mg film-coated tablets (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
6 | Ambrisentan 5mg film-coated tablets [marketed product] (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
7 | Ambrisentan plus Spironolactone (Letairis (TN)) | [2] Ambrisentan Ambrisentan (Letairis), Spironolactone | [2] Spironolactone
Spironolactone
,
Ambrisentan
(Letairis (TN)) 💬
| [2] EDNRA EDNRA, NR3C2 💬
| [8] Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
8 | Ambrisentan Tablet (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
9 | Bosentan, Ambrisentan (Letairis (TN)) | [2] Ambrisentan Ambrisentan (Letairis), Bosentan | [3] Bosentan
Bosentan
,
Ambrisentan
(Letairis (TN)),
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|
10 | Letairis | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
11 | Letairis 10 mg | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
12 | Letairis 5 mg | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 85 85 💬
|
13 | Tadalafil and ambrisentan upfront combination therapy (Letairis (TN)) | [2] Ambrisentan Ambrisentan (Letairis), Tadalafil | [2] Tadalafil
Tadalafil
,
Ambrisentan
(Letairis (TN)) 💬
| [2] EDNRA EDNRA, PDE5A 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
14 | VOLIBRIS® (ambrisentan) (Letairis (TN)) | [1] Ambrisentan Ambrisentan (Letairis) | [1] Ambrisentan
Ambrisentan
(Letairis (TN)) 💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 💬
|